Although previous reports have associated elevated BCKDK expression with high-grade ovarian cancer [9] and chemotherapy-resistant disease [10], the regulatory mechanisms of BCKDK expression and its role in metabolic reprogramming within TNBC remain unclear. This evidence concerns the gene BCKDK and ovarian carcinoma.